| abstract |
To perform safe and efficient IVR treatment without using an anticancer agent that damages normal cells. A cell growth inhibitor having apoptosis-inducing activity or at least one of bisphosphonate, vitamin K2 or derivatives thereof, and activated lymphocytes or dead cells such as AHCC and streptococci Alternatively, it is more preferable to administer a therapeutic agent mainly composed of at least one of one or more immunostimulants among the extract, mushrooms such as Maruyama vaccine, Agaricus koji, and the extract thereof. Has a great effect on the treatment of malignant tumors by combining administration of these therapeutic agents with IVR treatment. [Selection figure] None |